Status:
COMPLETED
Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections
Lead Sponsor:
Pfizer
Conditions:
Upper Respiratory Tract Infections
Eligibility:
All Genders
Brief Summary
To assess effectiveness of Trulimax (Azithromycin) in Acute Bacterial Upper Respiratory Tract Infections (URTIs).
Detailed Description
Prospective, Open-label, Non-interventional and Multi-center Study NA
Eligibility Criteria
Inclusion
- Evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the study.
- Patients with acute URTI, presumed to be of bacterial origin as per the clinical judgment of the investigator.
Exclusion
- N/A
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
421 Patients enrolled
Trial Details
Trial ID
NCT00827502
Start Date
February 1 2009
End Date
July 1 2009
Last Update
April 28 2011
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Jn Vishakhapatnam, Andhra Pradesh, India, 530001
2
Pfizer Investigational Site
Visakhapatnam, Andhra Pradesh, India, 530 020
3
Pfizer Investigational Site
Guwhati, Assam, India, 781 011
4
Pfizer Investigational Site
Nagpur, Maharashtra, India, 440 009